TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from Impact BioMedical, Inc. ( (IBO) ) is now available.
On July 21, 2025, Impact BioMedical Inc. entered into a Debt Conversion Agreement with DSS, Inc. to settle a $12 million loan originally made in March 2023. The agreement involves the issuance of 31,939,778 shares of common stock to DSS, fully satisfying the debt and any additional financial support provided by DSS up to the transaction’s closing.
More about Impact BioMedical, Inc.
Average Trading Volume: 11,314,788
Technical Sentiment Signal: Strong Sell
For an in-depth examination of IBO stock, go to TipRanks’ Overview page.